How has your company responded to recent challenges posed by updated standards and regulations in conducting clinical trials for Medical Devices? Our event - now in its second year - will provide a conducive environment to gain insight into these updates and amendments, as well as their impact on practice and strategy.
A diversity of experienced practitioners from Notified Bodies, Competent Authorities, CROs, and Medical Device Researchers… among others, will provide the basis for our industry’s continuing discourse on practice and research in Emerging markets. Join us here at Fleming Europe’s Pharma page for more info and updates as we move towards September.
Key speakers: - Founder, Medical Device Strategies, WMDO – Consultant
- Director Clinical Affairs Europe, ev3 (Covidien)
- Director Clinical Affairs, GE Healthcare
- Senior Medical Director, Boston Scientific
- President and Founder, Applied Research Consortium of Asia Ltd.
Key topics: - Receive firsthand comment and direction for the ISO 14155:2011 standard, as well as resources to stay current and on target.
- Match successful adjustments in clinical practice to challenges faced under the new standards and regulations.
- Identify key indictors and strategies when selecting CROs and Investigators.
- Extend your understanding and competitiveness when tapping into established as well as up and coming Emerging Markets.
- Gauge the evolving challenges and opportunities in emerging Asian markets.
- Achieve competitive advantage, and fulfill expectations earlier on when doing business in emerging markets.
- Streamline practices for Medical Monitoring in Clinical Trials.
Who should attend: Vice Presidents, Heads, Directors, Senior Managers and Managers of:
Clinical Research, Clinical Operations, Clinical Development, Clinical Project Leaders, Clinical Trials, Medical Directors, Regulatory Directors, R&D, Clinical Studies, Clinical Outsourcing, CROs, Academics, Patient Organizations, Clinical Research Associations & Institutes
